Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000253674 | SCV000052070 | benign | not specified | 2019-06-11 | criteria provided, single submitter | clinical testing | Variant summary: CACNA1C c.372-15G>A alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.023 in 248948 control chromosomes in the gnomAD database, including 99 homozygotes. The observed variant frequency is approximately 2343-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in CACNA1C causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.372-15G>A in individuals affected with Arrhythmia and no experimental evidence demonstrating its impact on protein function have been reported. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cite the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Prevention |
RCV000253674 | SCV000305447 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001610297 | SCV001834321 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002054480 | SCV002416278 | benign | Long QT syndrome | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496445 | SCV002810216 | benign | Timothy syndrome; Brugada syndrome 3; Long qt syndrome 8 | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001610297 | SCV005234216 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000253674 | SCV001920844 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000253674 | SCV001926562 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000253674 | SCV001957092 | benign | not specified | no assertion criteria provided | clinical testing |